Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 5
Submit an article Journal homepage
1,049
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia

John WhalenEvidera Inc., London, UKCorrespondence[email protected]
,
Ipek StillmanEvidera, Lexington, MA, USA
,
Apoorva AmbavaneEvidera Inc., London, UK
,
Eugene FelberBristol-Myers Squibb, Plainsboro, NJ, USA
,
Dinara MakenbaevaBristol-Myers Squibb, Plainsboro, NJ, USA
&
Bjorn BolinderBristol-Myers Squibb, Plainsboro, NJ, USA
Pages 445-461 | Accepted 26 Nov 2015, Published online: 22 Dec 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xiaomeng Yue, Ana L. Hincapie, Yuxiang Li & Jeff J. Guo. (2022) Safety and cost-effectiveness of ponatinib versus other tyrosine kinase inhibitors as second-line therapy in patients with chronic myeloid leukemia in the United States. Leukemia & Lymphoma 63:4, pages 946-954.
Read now
Monia Marchetti. (2017) Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 469-480.
Read now

Articles from other publishers (7)

Wang Cao, Yuncui Yu, Yingpeng Qiu, Lu Liu, Hao Zhang, Liwei Shi, Yue Xiao, Lulu Jia, Ruidong Zhang & Xiaoling Wang. (2022) Cost-effectiveness analysis of dasatinib versus imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia patients in China. BMC Health Services Research 22:1.
Crossref
Rumjhum Agrawal, Joao Vieira, Jacqueline Ryan, Harish Negi, Tanvi Rajput, Regina Corbin & Ricardo Viana. (2022) A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia. PharmacoEconomics 40:12, pages 1159-1186.
Crossref
Min Huang, Scott Ramsey, Weiguang Xue, Jipan Xie, James Pellissier & Andrew Briggs. (2021) Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models. PharmacoEconomics 40:3, pages 257-268.
Crossref
Massimiliano Bonifacio, Vikalp Maheshwari, Diana Tran, Gianluca Agostoni, Kalitsa Filioussi & Ricardo Viana. (2021) Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in Italy. PharmacoEconomics - Open 6:1, pages 95-104.
Crossref
Seth Rowley, Pat Garcia-Gonzalez, Jerald P. Radich, Ann Kim Novakowski, Irina Usherenko & Joseph B. Babigumira. (2021) Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Jie Fu, Yuchen Liu, Houwen Lin & Bin Wu. (2018) Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review. Clinical Drug Investigation 38:12, pages 1167-1178.
Crossref
Koung Jin Suh, Ji Yun Lee, Dong-Yeop Shin, Youngil Koh, Soo-Mee Bang, Sung-Soo Yoon, Seonyang Park, Inho Kim & Jeong-Ok Lee. (2017) Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials. International Journal of Hematology 106:2, pages 229-239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.